Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$3.89
-0.26%
Mkt Cap $195.59M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+182.8%
Consensus $11.00 vs current $3.89
NASDAQ·Healthcare·Biotechnology
$3.89
-0.26%
Mkt Cap $195.59M
Buy
1
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+182.8%
Consensus $11.00 vs current $3.89